| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |